btk inhibitor lupus
Compare Chronic Disease Management to BTK Inhibitor Lupus?
44% of lupus patients lack coordinated chronic disease management, leading to fragmented care. Traditional chronic disease management relies on multidisciplinary teams and routine monitoring, but BTK inhibitor therapy offers a targeted, rapid reduction in disease activity, making it a more efficient option for many lupus patients. Medical Disclaimer: This article